RecruitingNCT04166266

National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses

Sponsor

ANRS, Emerging Infectious Diseases

Enrollment

800 participants

Start Date

Feb 19, 2020

Study Type

OBSERVATIONAL

Conditions

Hepatitis B, Chronic Hepatitis D, Chronic

Summary

This is a multicentre observational study with prospective and retrospective data collection and retrospective data collection and biological collection from patients with HBV/HDV co-infection.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Blood draw for the laboratory assessment for people with hepatitis b, chronic and hepatitis d, chronic. The study is currently recruiting participants at 38 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBlood draw for the laboratory assessment

Blood sampling for the biobank and, in addition, as sub-studies are planned on sub-groups of patients, additional blood samples are planned for the patients in these sub-studies.

Locations(38)

CHU of Angers

Angers, France

Centre Hospitalier de la région annécienne

Annecy, France

Avicenne Hospital - Hepatology

Bobigny, France

Avicenne Hospital

Bobigny, France

Haut Lévêque Hospital

Bordeaux, France

Estaing Hospital

Clermont-Ferrand, France

Beaujon Hospital

Clichy, France

Centre Hospitalier Intercommunal

Créteil, France

Henri Mondor Hospital

Créteil, France

Bocage Hospital

Dijon, France

Michallon Hospital

Grenoble, France

Claude Huriez Hospital

Lille, France

Dupuytren Hospital

Limoges, France

Croix Rousse Hospital

Lyon, France

Edouard Herriot Hospital

Lyon, France

Hôpital de la Croix Rousse

Lyon, France

SAint Joseph Hospital

Marseille, France

Saint Eloi Hospital

Montpellier, France

Hotel Dieu Hospital

Nantes, France

Hôtel-Dieu Hospital

Nantes, France

l'Archet 2 Hospital

Nice, France

La Source Hospital

Orléans, France

Bichat-Claude Bernard Hospital

Paris, France

Cochin Hospital

Paris, France

Hôpital Tenon

Paris, France

La Pitié Salpêtrière Hospital

Paris, France

Lariboisière Hospital

Paris, France

Pitié-Salpêtrière Hospital

Paris, France

Saint Antoine Hospital

Paris, France

Saint Louis Hospital

Paris, France

Saint-Antoine Hospital

Paris, France

Pontchaillou Hospital

Rennes, France

Charles Nicolle Hospital

Rouen, France

Nouvel Hôpital Civil

Strasbourg, France

Hôpital Rangueil

Toulouse, France

Rangueil Hospital

Toulouse, France

Trousseau Hospital

Tours, France

Paul Brousse Hospital

Villejuif, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04166266

Related Trials

Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region

NCT073702078 locations

Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chronic Hepatitis D Infection

NCT076107722 locations

Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D

NCT074918482 locations

Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B

NCT066802324 locations

Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]

NCT062164701 location